Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4.
Orcutt KP, Parsons AD, Sibenaller ZA, Scarbrough PM, Zhu Y, Sobhakumari A, Wilke WW, Kalen AL, Goswami P, Miller FJ Jr, Spitz DR, Simons AL.
Orcutt KP, et al. Among authors: wilke ww.
Cancer Res. 2011 Jun 1;71(11):3932-40. doi: 10.1158/0008-5472.CAN-10-3425. Epub 2011 Apr 11.
Cancer Res. 2011.
PMID: 21482679
Free PMC article.